These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 657151

  • 21. Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse.
    Tobey RA.
    Cancer Res; 1972 Dec; 32(12):2720-5. PubMed ID: 4118765
    [No Abstract] [Full Text] [Related]

  • 22. X-ray repair replication in L1210 leukemia cells.
    Lee YC, Byfield JE, Bennett LR, Chan YM.
    Cancer Res; 1974 Oct; 34(10):2624-33. PubMed ID: 4472428
    [No Abstract] [Full Text] [Related]

  • 23. Influence of the stage of advancement of leukemia L1210 in mice on the optimal schedule of treatment of cytosine arabinoside (NSC-63878).
    Kline I, Woodman RJ, Gang M, Sirica A, Venditti JM, Goldin A.
    Cancer Chemother Rep; 1972 Jun; 56(3):327-34. PubMed ID: 19051491
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878).
    Shackney SE.
    Cancer Chemother Rep; 1970 Dec; 54(6):399-429. PubMed ID: 5527022
    [No Abstract] [Full Text] [Related]

  • 27. [The effects of cytosine arabinoside and daunomycin on cell kinetics in childhood acute myeloblastic leukemia].
    Tsukimoto I, Toyosaka H, Tashiro Y, Nagao T.
    Rinsho Ketsueki; 1973 Jul; 14(7):762-8. PubMed ID: 4517365
    [No Abstract] [Full Text] [Related]

  • 28. Differential cytotoxicity of cytosine arabinoside toward murine leukemia L1210 cells and murine bone marrow progenitor cells inhibited in nucleoside transport by cimicifugoside.
    Hemmi H.
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):565-8. PubMed ID: 6791252
    [Abstract] [Full Text] [Related]

  • 29. Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia.
    Momparier RL, Gonzales FA.
    Cancer Res; 1978 Sep; 38(9):2673-8. PubMed ID: 79443
    [No Abstract] [Full Text] [Related]

  • 30. Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinoside.
    Buchman VM, Svet-Maoldavsky GJ, Lichinitser MR, Mkheidze DM.
    Biomedicine; 1977 Jul; 27(5):179-80. PubMed ID: 922116
    [Abstract] [Full Text] [Related]

  • 31. Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors.
    Waga K, Furusawa S, Nagashima S, Saito K, Shishido H.
    Int J Hematol; 1992 Aug; 56(1):17-27. PubMed ID: 1391803
    [Abstract] [Full Text] [Related]

  • 32. In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.
    Tardi P, Johnstone S, Harasym N, Xie S, Harasym T, Zisman N, Harvie P, Bermudes D, Mayer L.
    Leuk Res; 2009 Jan; 33(1):129-39. PubMed ID: 18676016
    [Abstract] [Full Text] [Related]

  • 33. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY, Jolivet J, Leblond L, Hamelin B, Ouellet F, Barbeau S, Richard A, Gourdeau H.
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL, Homan ER.
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract] [Full Text] [Related]

  • 36. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
    Patterson D, Kravtsova VM, Petrova EM, Zabelina TS, Balaian LN.
    Ter Arkh; 1987 Apr; 59(12):81-6. PubMed ID: 3482131
    [Abstract] [Full Text] [Related]

  • 37. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA, Katz ME.
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [Abstract] [Full Text] [Related]

  • 38. Chemotherapeutic, carcinogenic, and cell-regulatory effects of triazenes.
    Schmid FA, Hutchison DJ.
    Cancer Res; 1974 Jul; 34(7):1671-5. PubMed ID: 4833916
    [No Abstract] [Full Text] [Related]

  • 39. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD, Bachur NR.
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract] [Full Text] [Related]

  • 40. R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
    Atassi G, Schaus C, Tagnon HJ.
    Eur J Cancer (1965); 1975 Sep; 11(9):609-14. PubMed ID: 1220976
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.